Rotary Pad Printing Machine
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Nucleic Acid Multiplex Assay Market Research Report 2023
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nucleic Acid Multiplex Assay Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Planar Nucleic Acid Assays
1.2.3 Bead-Based Nucleic Acid Assays
1.2.4 Other Nucleic Acid Assays
1.3 Market by Application
1.3.1 Global Nucleic Acid Multiplex Assay Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Hospitals & Research Institutes
1.3.4 Reference Laboratories
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nucleic Acid Multiplex Assay Market Perspective (2017-2028)
2.2 Nucleic Acid Multiplex Assay Growth Trends by Region
2.2.1 Nucleic Acid Multiplex Assay Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Nucleic Acid Multiplex Assay Historic Market Size by Region (2017-2022)
2.2.3 Nucleic Acid Multiplex Assay Forecasted Market Size by Region (2023-2028)
2.3 Nucleic Acid Multiplex Assay Market Dynamics
2.3.1 Nucleic Acid Multiplex Assay Industry Trends
2.3.2 Nucleic Acid Multiplex Assay Market Drivers
2.3.3 Nucleic Acid Multiplex Assay Market Challenges
2.3.4 Nucleic Acid Multiplex Assay Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nucleic Acid Multiplex Assay Players by Revenue
3.1.1 Global Top Nucleic Acid Multiplex Assay Players by Revenue (2017-2022)
3.1.2 Global Nucleic Acid Multiplex Assay Revenue Market Share by Players (2017-2022)
3.2 Global Nucleic Acid Multiplex Assay Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nucleic Acid Multiplex Assay Revenue
3.4 Global Nucleic Acid Multiplex Assay Market Concentration Ratio
3.4.1 Global Nucleic Acid Multiplex Assay Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid Multiplex Assay Revenue in 2021
3.5 Nucleic Acid Multiplex Assay Key Players Head office and Area Served
3.6 Key Players Nucleic Acid Multiplex Assay Product Solution and Service
3.7 Date of Enter into Nucleic Acid Multiplex Assay Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nucleic Acid Multiplex Assay Breakdown Data by Type
4.1 Global Nucleic Acid Multiplex Assay Historic Market Size by Type (2017-2022)
4.2 Global Nucleic Acid Multiplex Assay Forecasted Market Size by Type (2023-2028)
5 Nucleic Acid Multiplex Assay Breakdown Data by Application
5.1 Global Nucleic Acid Multiplex Assay Historic Market Size by Application (2017-2022)
5.2 Global Nucleic Acid Multiplex Assay Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Nucleic Acid Multiplex Assay Market Size (2017-2028)
6.2 North America Nucleic Acid Multiplex Assay Market Size by Country (2017-2022)
6.3 North America Nucleic Acid Multiplex Assay Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Nucleic Acid Multiplex Assay Market Size (2017-2028)
7.2 Europe Nucleic Acid Multiplex Assay Market Size by Country (2017-2022)
7.3 Europe Nucleic Acid Multiplex Assay Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nucleic Acid Multiplex Assay Market Size (2017-2028)
8.2 Asia-Pacific Nucleic Acid Multiplex Assay Market Size by Country (2017-2022)
8.3 Asia-Pacific Nucleic Acid Multiplex Assay Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Nucleic Acid Multiplex Assay Market Size (2017-2028)
9.2 Latin America Nucleic Acid Multiplex Assay Market Size by Country (2017-2022)
9.3 Latin America Nucleic Acid Multiplex Assay Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nucleic Acid Multiplex Assay Market Size (2017-2028)
10.2 Middle East & Africa Nucleic Acid Multiplex Assay Market Size by Country (2017-2022)
10.3 Middle East & Africa Nucleic Acid Multiplex Assay Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Luminex Corporation (US)
11.1.1 Luminex Corporation (US) Company Detail
11.1.2 Luminex Corporation (US) Business Overview
11.1.3 Luminex Corporation (US) Nucleic Acid Multiplex Assay Introduction
11.1.4 Luminex Corporation (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.1.5 Luminex Corporation (US) Recent Development
11.2 Thermo Fisher Scientific Inc. (US)
11.2.1 Thermo Fisher Scientific Inc. (US) Company Detail
11.2.2 Thermo Fisher Scientific Inc. (US) Business Overview
11.2.3 Thermo Fisher Scientific Inc. (US) Nucleic Acid Multiplex Assay Introduction
11.2.4 Thermo Fisher Scientific Inc. (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.2.5 Thermo Fisher Scientific Inc. (US) Recent Development
11.3 Illumina, Inc (US)
11.3.1 Illumina, Inc (US) Company Detail
11.3.2 Illumina, Inc (US) Business Overview
11.3.3 Illumina, Inc (US) Nucleic Acid Multiplex Assay Introduction
11.3.4 Illumina, Inc (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.3.5 Illumina, Inc (US) Recent Development
11.4 Bio-Rad Laboratories, Inc. (US)
11.4.1 Bio-Rad Laboratories, Inc. (US) Company Detail
11.4.2 Bio-Rad Laboratories, Inc. (US) Business Overview
11.4.3 Bio-Rad Laboratories, Inc. (US) Nucleic Acid Multiplex Assay Introduction
11.4.4 Bio-Rad Laboratories, Inc. (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.4.5 Bio-Rad Laboratories, Inc. (US) Recent Development
11.5 Qiagen N.V. (Netherlands)
11.5.1 Qiagen N.V. (Netherlands) Company Detail
11.5.2 Qiagen N.V. (Netherlands) Business Overview
11.5.3 Qiagen N.V. (Netherlands) Nucleic Acid Multiplex Assay Introduction
11.5.4 Qiagen N.V. (Netherlands) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.5.5 Qiagen N.V. (Netherlands) Recent Development
11.6 Abcam plc (UK)
11.6.1 Abcam plc (UK) Company Detail
11.6.2 Abcam plc (UK) Business Overview
11.6.3 Abcam plc (UK) Nucleic Acid Multiplex Assay Introduction
11.6.4 Abcam plc (UK) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.6.5 Abcam plc (UK) Recent Development
11.7 Becton, Dickinson and Company (US)
11.7.1 Becton, Dickinson and Company (US) Company Detail
11.7.2 Becton, Dickinson and Company (US) Business Overview
11.7.3 Becton, Dickinson and Company (US) Nucleic Acid Multiplex Assay Introduction
11.7.4 Becton, Dickinson and Company (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.7.5 Becton, Dickinson and Company (US) Recent Development
11.8 Merck KGaA (Germany)
11.8.1 Merck KGaA (Germany) Company Detail
11.8.2 Merck KGaA (Germany) Business Overview
11.8.3 Merck KGaA (Germany) Nucleic Acid Multiplex Assay Introduction
11.8.4 Merck KGaA (Germany) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.8.5 Merck KGaA (Germany) Recent Development
11.9 Agilent Technologies, Inc. (US)
11.9.1 Agilent Technologies, Inc. (US) Company Detail
11.9.2 Agilent Technologies, Inc. (US) Business Overview
11.9.3 Agilent Technologies, Inc. (US) Nucleic Acid Multiplex Assay Introduction
11.9.4 Agilent Technologies, Inc. (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.9.5 Agilent Technologies, Inc. (US) Recent Development
11.10 Meso Scale Diagnostics (US)
11.10.1 Meso Scale Diagnostics (US) Company Detail
11.10.2 Meso Scale Diagnostics (US) Business Overview
11.10.3 Meso Scale Diagnostics (US) Nucleic Acid Multiplex Assay Introduction
11.10.4 Meso Scale Diagnostics (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.10.5 Meso Scale Diagnostics (US) Recent Development
11.11 Randox Laboratories (UK)
11.11.1 Randox Laboratories (UK) Company Detail
11.11.2 Randox Laboratories (UK) Business Overview
11.11.3 Randox Laboratories (UK) Nucleic Acid Multiplex Assay Introduction
11.11.4 Randox Laboratories (UK) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.11.5 Randox Laboratories (UK) Recent Development
11.12 Quanterix (US)
11.12.1 Quanterix (US) Company Detail
11.12.2 Quanterix (US) Business Overview
11.12.3 Quanterix (US) Nucleic Acid Multiplex Assay Introduction
11.12.4 Quanterix (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.12.5 Quanterix (US) Recent Development
11.13 Bio-Techne Corporation (US)
11.13.1 Bio-Techne Corporation (US) Company Detail
11.13.2 Bio-Techne Corporation (US) Business Overview
11.13.3 Bio-Techne Corporation (US) Nucleic Acid Multiplex Assay Introduction
11.13.4 Bio-Techne Corporation (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.13.5 Bio-Techne Corporation (US) Recent Development
11.14 Olink (Sweden)
11.14.1 Olink (Sweden) Company Detail
11.14.2 Olink (Sweden) Business Overview
11.14.3 Olink (Sweden) Nucleic Acid Multiplex Assay Introduction
11.14.4 Olink (Sweden) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.14.5 Olink (Sweden) Recent Development
11.15 DiaSorin S.p.A. (Italy)
11.15.1 DiaSorin S.p.A. (Italy) Company Detail
11.15.2 DiaSorin S.p.A. (Italy) Business Overview
11.15.3 DiaSorin S.p.A. (Italy) Nucleic Acid Multiplex Assay Introduction
11.15.4 DiaSorin S.p.A. (Italy) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.15.5 DiaSorin S.p.A. (Italy) Recent Development
11.16 Seegene (South Korea)
11.16.1 Seegene (South Korea) Company Detail
11.16.2 Seegene (South Korea) Business Overview
11.16.3 Seegene (South Korea) Nucleic Acid Multiplex Assay Introduction
11.16.4 Seegene (South Korea) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.16.5 Seegene (South Korea) Recent Development
11.17 Promega Corporation (US)
11.17.1 Promega Corporation (US) Company Detail
11.17.2 Promega Corporation (US) Business Overview
11.17.3 Promega Corporation (US) Nucleic Acid Multiplex Assay Introduction
11.17.4 Promega Corporation (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.17.5 Promega Corporation (US) Recent Development
11.18 Siemens Healthineers (Germany)
11.18.1 Siemens Healthineers (Germany) Company Detail
11.18.2 Siemens Healthineers (Germany) Business Overview
11.18.3 Siemens Healthineers (Germany) Nucleic Acid Multiplex Assay Introduction
11.18.4 Siemens Healthineers (Germany) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.18.5 Siemens Healthineers (Germany) Recent Development
11.19 PerkinElmer, Inc. (US)
11.19.1 PerkinElmer, Inc. (US) Company Detail
11.19.2 PerkinElmer, Inc. (US) Business Overview
11.19.3 PerkinElmer, Inc. (US) Nucleic Acid Multiplex Assay Introduction
11.19.4 PerkinElmer, Inc. (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.19.5 PerkinElmer, Inc. (US) Recent Development
11.20 Shimadzu Biotech (Japan)
11.20.1 Shimadzu Biotech (Japan) Company Detail
11.20.2 Shimadzu Biotech (Japan) Business Overview
11.20.3 Shimadzu Biotech (Japan) Nucleic Acid Multiplex Assay Introduction
11.20.4 Shimadzu Biotech (Japan) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.20.5 Shimadzu Biotech (Japan) Recent Development
11.21 Antigenix America, Inc. (US)
11.21.1 Antigenix America, Inc. (US) Company Detail
11.21.2 Antigenix America, Inc. (US) Business Overview
11.21.3 Antigenix America, Inc. (US) Nucleic Acid Multiplex Assay Introduction
11.21.4 Antigenix America, Inc. (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.21.5 Antigenix America, Inc. (US) Recent Development
11.22 Enzo Life Sciences, Inc. (US)
11.22.1 Enzo Life Sciences, Inc. (US) Company Detail
11.22.2 Enzo Life Sciences, Inc. (US) Business Overview
11.22.3 Enzo Life Sciences, Inc. (US) Nucleic Acid Multiplex Assay Introduction
11.22.4 Enzo Life Sciences, Inc. (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.22.5 Enzo Life Sciences, Inc. (US) Recent Development
11.23 Boster Biological Technology (US)
11.23.1 Boster Biological Technology (US) Company Detail
11.23.2 Boster Biological Technology (US) Business Overview
11.23.3 Boster Biological Technology (US) Nucleic Acid Multiplex Assay Introduction
11.23.4 Boster Biological Technology (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.23.5 Boster Biological Technology (US) Recent Development
11.24 AYOXXA Biosystems GmbH (Germany)
11.24.1 AYOXXA Biosystems GmbH (Germany) Company Detail
11.24.2 AYOXXA Biosystems GmbH (Germany) Business Overview
11.24.3 AYOXXA Biosystems GmbH (Germany) Nucleic Acid Multiplex Assay Introduction
11.24.4 AYOXXA Biosystems GmbH (Germany) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.24.5 AYOXXA Biosystems GmbH (Germany) Recent Development
11.25 Cayman Chemical Company (US)
11.25.1 Cayman Chemical Company (US) Company Detail
11.25.2 Cayman Chemical Company (US) Business Overview
11.25.3 Cayman Chemical Company (US) Nucleic Acid Multiplex Assay Introduction
11.25.4 Cayman Chemical Company (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.25.5 Cayman Chemical Company (US) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Nucleic Acid Multiplex Assay Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Planar Nucleic Acid Assays
Table 3. Key Players of Bead-Based Nucleic Acid Assays
Table 4. Key Players of Other Nucleic Acid Assays
Table 5. Global Nucleic Acid Multiplex Assay Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Nucleic Acid Multiplex Assay Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Nucleic Acid Multiplex Assay Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Nucleic Acid Multiplex Assay Market Share by Region (2017-2022)
Table 9. Global Nucleic Acid Multiplex Assay Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Nucleic Acid Multiplex Assay Market Share by Region (2023-2028)
Table 11. Nucleic Acid Multiplex Assay Market Trends
Table 12. Nucleic Acid Multiplex Assay Market Drivers
Table 13. Nucleic Acid Multiplex Assay Market Challenges
Table 14. Nucleic Acid Multiplex Assay Market Restraints
Table 15. Global Nucleic Acid Multiplex Assay Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Nucleic Acid Multiplex Assay Market Share by Players (2017-2022)
Table 17. Global Top Nucleic Acid Multiplex Assay Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Multiplex Assay as of 2021)
Table 18. Ranking of Global Top Nucleic Acid Multiplex Assay Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Nucleic Acid Multiplex Assay Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Nucleic Acid Multiplex Assay Product Solution and Service
Table 22. Date of Enter into Nucleic Acid Multiplex Assay Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Nucleic Acid Multiplex Assay Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Nucleic Acid Multiplex Assay Revenue Market Share by Type (2017-2022)
Table 26. Global Nucleic Acid Multiplex Assay Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Nucleic Acid Multiplex Assay Revenue Market Share by Type (2023-2028)
Table 28. Global Nucleic Acid Multiplex Assay Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Nucleic Acid Multiplex Assay Revenue Market Share by Application (2017-2022)
Table 30. Global Nucleic Acid Multiplex Assay Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Nucleic Acid Multiplex Assay Revenue Market Share by Application (2023-2028)
Table 32. North America Nucleic Acid Multiplex Assay Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Nucleic Acid Multiplex Assay Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Nucleic Acid Multiplex Assay Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Nucleic Acid Multiplex Assay Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Nucleic Acid Multiplex Assay Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Nucleic Acid Multiplex Assay Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Nucleic Acid Multiplex Assay Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Nucleic Acid Multiplex Assay Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Nucleic Acid Multiplex Assay Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Nucleic Acid Multiplex Assay Market Size by Country (2023-2028) & (US$ Million)
Table 42. Luminex Corporation (US) Company Detail
Table 43. Luminex Corporation (US) Business Overview
Table 44. Luminex Corporation (US) Nucleic Acid Multiplex Assay Product
Table 45. Luminex Corporation (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022) & (US$ Million)
Table 46. Luminex Corporation (US) Recent Development
Table 47. Thermo Fisher Scientific Inc. (US) Company Detail
Table 48. Thermo Fisher Scientific Inc. (US) Business Overview
Table 49. Thermo Fisher Scientific Inc. (US) Nucleic Acid Multiplex Assay Product
Table 50. Thermo Fisher Scientific Inc. (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022) & (US$ Million)
Table 51. Thermo Fisher Scientific Inc. (US) Recent Development
Table 52. Illumina, Inc (US) Company Detail
Table 53. Illumina, Inc (US) Business Overview
Table 54. Illumina, Inc (US) Nucleic Acid Multiplex Assay Product
Table 55. Illumina, Inc (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022) & (US$ Million)
Table 56. Illumina, Inc (US) Recent Development
Table 57. Bio-Rad Laboratories, Inc. (US) Company Detail
Table 58. Bio-Rad Laboratories, Inc. (US) Business Overview
Table 59. Bio-Rad Laboratories, Inc. (US) Nucleic Acid Multiplex Assay Product
Table 60. Bio-Rad Laboratories, Inc. (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022) & (US$ Million)
Table 61. Bio-Rad Laboratories, Inc. (US) Recent Development
Table 62. Qiagen N.V. (Netherlands) Company Detail
Table 63. Qiagen N.V. (Netherlands) Business Overview
Table 64. Qiagen N.V. (Netherlands) Nucleic Acid Multiplex Assay Product
Table 65. Qiagen N.V. (Netherlands) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022) & (US$ Million)
Table 66. Qiagen N.V. (Netherlands) Recent Development
Table 67. Abcam plc (UK) Company Detail
Table 68. Abcam plc (UK) Business Overview
Table 69. Abcam plc (UK) Nucleic Acid Multiplex Assay Product
Table 70. Abcam plc (UK) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022) & (US$ Million)
Table 71. Abcam plc (UK) Recent Development
Table 72. Becton, Dickinson and Company (US) Company Detail
Table 73. Becton, Dickinson and Company (US) Business Overview
Table 74. Becton, Dickinson and Company (US) Nucleic Acid Multiplex Assay Product
Table 75. Becton, Dickinson and Company (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022) & (US$ Million)
Table 76. Becton, Dickinson and Company (US) Recent Development
Table 77. Merck KGaA (Germany) Company Detail
Table 78. Merck KGaA (Germany) Business Overview
Table 79. Merck KGaA (Germany) Nucleic Acid Multiplex Assay Product
Table 80. Merck KGaA (Germany) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022) & (US$ Million)
Table 81. Merck KGaA (Germany) Recent Development
Table 82. Agilent Technologies, Inc. (US) Company Detail
Table 83. Agilent Technologies, Inc. (US) Business Overview
Table 84. Agilent Technologies, Inc. (US) Nucleic Acid Multiplex Assay Product
Table 85. Agilent Technologies, Inc. (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022) & (US$ Million)
Table 86. Agilent Technologies, Inc. (US) Recent Development
Table 87. Meso Scale Diagnostics (US) Company Detail
Table 88. Meso Scale Diagnostics (US) Business Overview
Table 89. Meso Scale Diagnostics (US) Nucleic Acid Multiplex Assay Product
Table 90. Meso Scale Diagnostics (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022) & (US$ Million)
Table 91. Meso Scale Diagnostics (US) Recent Development
Table 92. Randox Laboratories (UK) Company Detail
Table 93. Randox Laboratories (UK) Business Overview
Table 94. Randox Laboratories (UK) Nucleic Acid Multiplex AssayProduct
Table 95. Randox Laboratories (UK) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022) & (US$ Million)
Table 96. Randox Laboratories (UK) Recent Development
Table 97. Quanterix (US) Company Detail
Table 98. Quanterix (US) Business Overview
Table 99. Quanterix (US) Nucleic Acid Multiplex AssayProduct
Table 100. Quanterix (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022) & (US$ Million)
Table 101. Quanterix (US) Recent Development
Table 102. Bio-Techne Corporation (US) Company Detail
Table 103. Bio-Techne Corporation (US) Business Overview
Table 104. Bio-Techne Corporation (US) Nucleic Acid Multiplex AssayProduct
Table 105. Bio-Techne Corporation (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022) & (US$ Million)
Table 106. Bio-Techne Corporation (US) Recent Development
Table 107. Olink (Sweden) Company Detail
Table 108. Olink (Sweden) Business Overview
Table 109. Olink (Sweden) Nucleic Acid Multiplex AssayProduct
Table 110. Olink (Sweden) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022) & (US$ Million)
Table 111. Olink (Sweden) Recent Development
Table 112. DiaSorin S.p.A. (Italy) Company Detail
Table 113. DiaSorin S.p.A. (Italy) Business Overview
Table 114. DiaSorin S.p.A. (Italy) Nucleic Acid Multiplex AssayProduct
Table 115. DiaSorin S.p.A. (Italy) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022) & (US$ Million)
Table 116. DiaSorin S.p.A. (Italy) Recent Development
Table 117. Seegene (South Korea) Company Detail
Table 118. Seegene (South Korea) Business Overview
Table 119. Seegene (South Korea) Nucleic Acid Multiplex AssayProduct
Table 120. Seegene (South Korea) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022) & (US$ Million)
Table 121. Seegene (South Korea) Recent Development
Table 122. Promega Corporation (US) Company Detail
Table 123. Promega Corporation (US) Business Overview
Table 124. Promega Corporation (US) Nucleic Acid Multiplex AssayProduct
Table 125. Promega Corporation (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022) & (US$ Million)
Table 126. Promega Corporation (US) Recent Development
Table 127. Siemens Healthineers (Germany) Company Detail
Table 128. Siemens Healthineers (Germany) Business Overview
Table 129. Siemens Healthineers (Germany) Nucleic Acid Multiplex AssayProduct
Table 130. Siemens Healthineers (Germany) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022) & (US$ Million)
Table 131. Siemens Healthineers (Germany) Recent Development
Table 132. PerkinElmer, Inc. (US) Company Detail
Table 133. PerkinElmer, Inc. (US) Business Overview
Table 134. PerkinElmer, Inc. (US) Nucleic Acid Multiplex AssayProduct
Table 135. PerkinElmer, Inc. (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022) & (US$ Million)
Table 136. PerkinElmer, Inc. (US) Recent Development
Table 137. Shimadzu Biotech (Japan) Company Detail
Table 138. Shimadzu Biotech (Japan) Business Overview
Table 139. Shimadzu Biotech (Japan) Nucleic Acid Multiplex AssayProduct
Table 140. Shimadzu Biotech (Japan) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022) & (US$ Million)
Table 141. Shimadzu Biotech (Japan) Recent Development
Table 142. Antigenix America, Inc. (US) Company Detail
Table 143. Antigenix America, Inc. (US) Business Overview
Table 144. Antigenix America, Inc. (US) Nucleic Acid Multiplex AssayProduct
Table 145. Antigenix America, Inc. (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022) & (US$ Million)
Table 146. Antigenix America, Inc. (US) Recent Development
Table 147. Enzo Life Sciences, Inc. (US) Company Detail
Table 148. Enzo Life Sciences, Inc. (US) Business Overview
Table 149. Enzo Life Sciences, Inc. (US) Nucleic Acid Multiplex AssayProduct
Table 150. Enzo Life Sciences, Inc. (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022) & (US$ Million)
Table 151. Enzo Life Sciences, Inc. (US) Recent Development
Table 152. Boster Biological Technology (US) Company Detail
Table 153. Boster Biological Technology (US) Business Overview
Table 154. Boster Biological Technology (US) Nucleic Acid Multiplex AssayProduct
Table 155. Boster Biological Technology (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022) & (US$ Million)
Table 156. Boster Biological Technology (US) Recent Development
Table 157. AYOXXA Biosystems GmbH (Germany) Company Detail
Table 158. AYOXXA Biosystems GmbH (Germany) Business Overview
Table 159. AYOXXA Biosystems GmbH (Germany) Nucleic Acid Multiplex AssayProduct
Table 160. AYOXXA Biosystems GmbH (Germany) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022) & (US$ Million)
Table 161. AYOXXA Biosystems GmbH (Germany) Recent Development
Table 162. Cayman Chemical Company (US) Company Detail
Table 163. Cayman Chemical Company (US) Business Overview
Table 164. Cayman Chemical Company (US) Nucleic Acid Multiplex AssayProduct
Table 165. Cayman Chemical Company (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022) & (US$ Million)
Table 166. Cayman Chemical Company (US) Recent Development
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nucleic Acid Multiplex Assay Market Share by Type: 2021 VS 2028
Figure 2. Planar Nucleic Acid Assays Features
Figure 3. Bead-Based Nucleic Acid Assays Features
Figure 4. Other Nucleic Acid Assays Features
Figure 5. Global Nucleic Acid Multiplex Assay Market Share by Application in 2021 & 2028
Figure 6. Pharmaceutical & Biotechnology Companies Case Studies
Figure 7. Hospitals & Research Institutes Case Studies
Figure 8. Reference Laboratories Case Studies
Figure 9. Other Case Studies
Figure 10. Nucleic Acid Multiplex Assay Report Years Considered
Figure 11. Global Nucleic Acid Multiplex Assay Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Nucleic Acid Multiplex Assay Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Nucleic Acid Multiplex Assay Market Share by Region: 2021 VS 2028
Figure 14. Global Nucleic Acid Multiplex Assay Market Share by Players in 2021
Figure 15. Global Top Nucleic Acid Multiplex Assay Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Multiplex Assay as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Nucleic Acid Multiplex Assay Revenue in 2021
Figure 17. North America Nucleic Acid Multiplex Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Nucleic Acid Multiplex Assay Market Share by Country (2017-2028)
Figure 19. United States Nucleic Acid Multiplex Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Nucleic Acid Multiplex Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Nucleic Acid Multiplex Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Nucleic Acid Multiplex Assay Market Share by Country (2017-2028)
Figure 23. Germany Nucleic Acid Multiplex Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Nucleic Acid Multiplex Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Nucleic Acid Multiplex Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Nucleic Acid Multiplex Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Nucleic Acid Multiplex Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Nucleic Acid Multiplex Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Nucleic Acid Multiplex Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Nucleic Acid Multiplex Assay Market Share by Region (2017-2028)
Figure 31. China Nucleic Acid Multiplex Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Nucleic Acid Multiplex Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Nucleic Acid Multiplex Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Nucleic Acid Multiplex Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Nucleic Acid Multiplex Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Nucleic Acid Multiplex Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Nucleic Acid Multiplex Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Nucleic Acid Multiplex Assay Market Share by Country (2017-2028)
Figure 39. Mexico Nucleic Acid Multiplex Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Nucleic Acid Multiplex Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Nucleic Acid Multiplex Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Nucleic Acid Multiplex Assay Market Share by Country (2017-2028)
Figure 43. Turkey Nucleic Acid Multiplex Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Nucleic Acid Multiplex Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Luminex Corporation (US) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2017-2022)
Figure 46. Thermo Fisher Scientific Inc. (US) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2017-2022)
Figure 47. Illumina, Inc (US) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2017-2022)
Figure 48. Bio-Rad Laboratories, Inc. (US) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2017-2022)
Figure 49. Qiagen N.V. (Netherlands) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2017-2022)
Figure 50. Abcam plc (UK) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2017-2022)
Figure 51. Becton, Dickinson and Company (US) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2017-2022)
Figure 52. Merck KGaA (Germany) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2017-2022)
Figure 53. Agilent Technologies, Inc. (US) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2017-2022)
Figure 54. Meso Scale Diagnostics (US) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2017-2022)
Figure 55. Randox Laboratories (UK) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2017-2022)
Figure 56. Quanterix (US) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2017-2022)
Figure 57. Bio-Techne Corporation (US) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2017-2022)
Figure 58. Olink (Sweden) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2017-2022)
Figure 59. DiaSorin S.p.A. (Italy) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2017-2022)
Figure 60. Seegene (South Korea) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2017-2022)
Figure 61. Promega Corporation (US) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2017-2022)
Figure 62. Siemens Healthineers (Germany) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2017-2022)
Figure 63. PerkinElmer, Inc. (US) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2017-2022)
Figure 64. Shimadzu Biotech (Japan) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2017-2022)
Figure 65. Antigenix America, Inc. (US) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2017-2022)
Figure 66. Enzo Life Sciences, Inc. (US) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2017-2022)
Figure 67. Boster Biological Technology (US) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2017-2022)
Figure 68. AYOXXA Biosystems GmbH (Germany) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2017-2022)
Figure 69. Cayman Chemical Company (US) Revenue Growth Rate in Nucleic Acid Multiplex Assay Business (2017-2022)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Luminex Corporation (US) Thermo Fisher Scientific Inc. (US) Illumina, Inc (US) Bio-Rad Laboratories, Inc. (US) Qiagen N.V. (Netherlands) Abcam plc (UK) Becton, Dickinson and Company (US) Merck KGaA (Germany) Agilent Technologies, Inc. (US) Meso Scale Diagnostics (US) Randox Laboratories (UK) Quanterix (US) Bio-Techne Corporation (US) Olink (Sweden) DiaSorin S.p.A. (Italy) Seegene (South Korea) Promega Corporation (US) Siemens Healthineers (Germany) PerkinElmer, Inc. (US) Shimadzu Biotech (Japan) Antigenix America, Inc. (US) Enzo Life Sciences, Inc. (US) Boster Biological Technology (US) AYOXXA Biosystems GmbH (Germany) Cayman Chemical Company (US)